Medinotec (MDNC) EBITDA Margin (2022 - 2026)
Medinotec posted quarterly EBITDA Margin of 26.13% for Q4 2025, up 1458.0% year-on-year from 1.68% in Q4 2024, and up 135.19% on a QoQ basis from 11.11% in Q3 2025.
Medinotec (MDNC) has 4 years of EBITDA Margin data on file, last reported at 26.13% in Q4 2025.
- For the quarter ending Q4 2025, EBITDA Margin rose 1458.0% year-over-year to 26.13%; the trailing twelve-month figure through Nov 2025 stood at 22.44% (up 1290.0% YoY), and the FY2025 full-year result was 23.08%, up 3083.0% from the prior year.
- EBITDA Margin for Q4 2025 stood at 26.13%, up from 11.11% in the prior quarter.
- Across five years, EBITDA Margin topped out at 40.99% in Q1 2025 and bottomed at 108.23% in Q3 2022.
- The 4-year median for EBITDA Margin is 4.34% (2025), against an average of 5.18%.
- Peak annual rise in EBITDA Margin reached 9232 bps in 2023, while the deepest fall reached 1198 bps in 2023.
- A 4-year view of EBITDA Margin shows it stood at 12.58% in 2022, then plunged by 95 bps to 24.56% in 2023, then surged by 147 bps to 11.54% in 2024, then jumped by 126 bps to 26.13% in 2025.
- The last three EBITDA Margin figures came in at 26.13% (Q4 2025), 11.11% (Q3 2025), and 4.59% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Medinotec | - | - | 854,557.00 | 11.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 11.58% |
| Nov 30, 2025 | 26.13% |
| Aug 31, 2025 | 11.11% |
| May 31, 2025 | 4.59% |
| Feb 28, 2025 | 40.99% |
| Nov 30, 2024 | 11.54% |
| Aug 31, 2024 | 15.49% |
| May 31, 2024 | 6.63% |
| Feb 29, 2024 | 4.08% |
| Nov 30, 2023 | -24.56% |
| Aug 31, 2023 | -15.90% |
| May 31, 2023 | 16.07% |
| Feb 28, 2023 | -10.17% |
| Nov 30, 2022 | -12.58% |
| Aug 31, 2022 | -108.23% |
| May 31, 2022 | -27.77% |
| Feb 28, 2022 | -20.35% |